Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Company News For April 03, 2017

ByZacks Investment Research
Published 04/02/2017, 10:22 PM
Updated 07/09/2023, 06:31 AM
• Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business.
• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
• Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business.
• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
• Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business.
• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
• Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business.
• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
  • Shares of FMC Corporation (NYSE:FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (NYSE:DD) crop protection business.
  • BlackBerry Ltd’s (NASDAQ:BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
  • Shares of Akari Therapeutics, Plc (NASDAQ:AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
  • TRC Companies, Inc.’s (NYSE:TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
• Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business.
• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the compan


E.I. du Pont de Nemours and Company (DD): Free Stock Analysis Report

FMC Corporation (FMC): Free Stock Analysis Report

BlackBerry Limited (BBRY): Free Stock Analysis Report

Akari Therapeutics PLC (AKTX): Free Stock Analysis Report

Original post

Zacks Investment Research
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.